Harbin Medisan Pharmaceutical Co Ltd
SZSE:002900
Harbin Medisan Pharmaceutical Co Ltd
SZSE:002900
Price:
11.13
CNY
-0.54%
Market Closed
Market Cap:
¥3.5B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Harbin Medisan Pharmaceutical Co Ltd
SZSE:002900
|
CN |
|
Shen Zhen Shengxunda Technology Co Ltd
SZSE:300518
|
CN |
|
Chewy Inc
NYSE:CHWY
|
US |
|
GIFT Holdings Inc
TSE:9279
|
JP |
|
I
|
Inox Green Energy Services Ltd
NSE:INOXGREEN
|
IN |
|
I
|
Inmobiliaria San Patricio SA
SGO:ISANPA
|
CL |
|
Macrotech Developers Ltd
BSE:543287
|
IN |
Income Statement
Earnings Waterfall
Harbin Medisan Pharmaceutical Co Ltd
Harbin Medisan Pharmaceutical Co Ltd
Income Statement
Harbin Medisan Pharmaceutical Co Ltd
Harbin Medisan Pharmaceutical Co Ltd
Currency: CNY
| Jun-2017 | Sep-2017 | Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||||||||||||||||||||||
| Interest Expense |
0
|
2
|
5
|
0
|
0
|
1
|
2
|
2
|
3
|
5
|
6
|
8
|
8
|
7
|
9
|
10
|
11
|
12
|
14
|
16
|
19
|
23
|
23
|
24
|
23
|
23
|
23
|
24
|
27
|
29
|
31
|
32
|
0
|
0
|
|
| Revenue |
793
N/A
|
895
+13%
|
1 149
+28%
|
1 451
+26%
|
1 762
+21%
|
2 057
+17%
|
2 173
+6%
|
2 201
+1%
|
2 304
+5%
|
2 228
-3%
|
2 102
-6%
|
1 890
-10%
|
1 603
-15%
|
1 437
-10%
|
1 339
-7%
|
1 280
-4%
|
1 186
-7%
|
1 080
-9%
|
946
-12%
|
972
+3%
|
977
+0%
|
1 000
+2%
|
1 028
+3%
|
1 114
+8%
|
1 161
+4%
|
1 189
+2%
|
1 187
0%
|
1 091
-8%
|
1 073
-2%
|
1 103
+3%
|
1 132
+3%
|
1 091
-4%
|
1 022
-6%
|
875
-14%
|
|
| Gross Profit | |||||||||||||||||||||||||||||||||||
| Cost of Revenue |
(323)
|
(328)
|
(298)
|
(337)
|
(347)
|
(379)
|
(355)
|
(413)
|
(453)
|
(480)
|
(513)
|
(536)
|
(512)
|
(514)
|
(487)
|
(485)
|
(457)
|
(397)
|
(313)
|
(345)
|
(351)
|
(364)
|
(360)
|
(405)
|
(418)
|
(461)
|
(476)
|
(468)
|
(506)
|
(551)
|
(554)
|
(574)
|
(562)
|
(492)
|
|
| Gross Profit |
470
N/A
|
567
+21%
|
851
+50%
|
1 114
+31%
|
1 416
+27%
|
1 678
+19%
|
1 818
+8%
|
1 788
-2%
|
1 851
+4%
|
1 748
-6%
|
1 589
-9%
|
1 354
-15%
|
1 091
-19%
|
923
-15%
|
852
-8%
|
795
-7%
|
728
-8%
|
683
-6%
|
633
-7%
|
627
-1%
|
626
0%
|
636
+2%
|
668
+5%
|
709
+6%
|
743
+5%
|
728
-2%
|
711
-2%
|
623
-12%
|
567
-9%
|
552
-3%
|
579
+5%
|
516
-11%
|
461
-11%
|
383
-17%
|
|
| Operating Income | |||||||||||||||||||||||||||||||||||
| Operating Expenses |
(263)
|
(344)
|
(623)
|
(878)
|
(1 186)
|
(1 459)
|
(1 600)
|
(1 600)
|
(1 639)
|
(1 528)
|
(1 385)
|
(1 157)
|
(960)
|
(842)
|
(784)
|
(783)
|
(745)
|
(725)
|
(767)
|
(764)
|
(747)
|
(745)
|
(681)
|
(695)
|
(730)
|
(715)
|
(692)
|
(625)
|
(555)
|
(526)
|
(531)
|
(500)
|
(518)
|
(577)
|
|
| Selling, General & Administrative |
(263)
|
(328)
|
(553)
|
(878)
|
(1 199)
|
(1 478)
|
(1 561)
|
(1 579)
|
(1 596)
|
(1 486)
|
(1 286)
|
(1 099)
|
(901)
|
(784)
|
(726)
|
(717)
|
(667)
|
(636)
|
(649)
|
(674)
|
(663)
|
(665)
|
(576)
|
(634)
|
(655)
|
(635)
|
(581)
|
(537)
|
(476)
|
(443)
|
(415)
|
(414)
|
(429)
|
(448)
|
|
| Research & Development |
0
|
(16)
|
(69)
|
0
|
0
|
(20)
|
(68)
|
(60)
|
(81)
|
(81)
|
(101)
|
(112)
|
(125)
|
(130)
|
(99)
|
(113)
|
(105)
|
(102)
|
(86)
|
(94)
|
(89)
|
(93)
|
(77)
|
(94)
|
(104)
|
(104)
|
(100)
|
(117)
|
(109)
|
(111)
|
(96)
|
(99)
|
(95)
|
(93)
|
|
| Depreciation & Amortization |
0
|
0
|
(20)
|
0
|
0
|
0
|
(34)
|
0
|
0
|
0
|
(38)
|
0
|
0
|
0
|
(42)
|
0
|
0
|
0
|
(48)
|
0
|
0
|
0
|
(48)
|
0
|
0
|
0
|
(42)
|
0
|
0
|
0
|
(40)
|
0
|
0
|
0
|
|
| Other Operating Expenses |
1
|
(0)
|
20
|
1
|
13
|
39
|
63
|
39
|
38
|
40
|
41
|
54
|
67
|
71
|
83
|
47
|
27
|
13
|
15
|
4
|
4
|
13
|
19
|
32
|
29
|
24
|
31
|
29
|
30
|
27
|
19
|
13
|
6
|
(36)
|
|
| Operating Income |
207
N/A
|
223
+7%
|
228
+2%
|
237
+4%
|
230
-3%
|
219
-5%
|
218
-1%
|
188
-14%
|
212
+12%
|
221
+4%
|
204
-7%
|
197
-3%
|
131
-33%
|
81
-38%
|
68
-16%
|
12
-82%
|
(17)
N/A
|
(42)
-147%
|
(134)
-223%
|
(137)
-2%
|
(121)
+11%
|
(109)
+10%
|
(13)
+88%
|
14
N/A
|
13
-12%
|
14
+8%
|
19
+42%
|
(2)
N/A
|
11
N/A
|
25
+127%
|
47
+86%
|
16
-66%
|
(57)
N/A
|
(194)
-241%
|
|
| Pre-Tax Income | |||||||||||||||||||||||||||||||||||
| Interest Income Expense |
26
|
26
|
27
|
62
|
85
|
84
|
50
|
57
|
9
|
3
|
29
|
4
|
(10)
|
(19)
|
(25)
|
552
|
617
|
598
|
36
|
27
|
3
|
43
|
67
|
85
|
76
|
79
|
62
|
59
|
34
|
31
|
15
|
(8)
|
(8)
|
(10)
|
|
| Non-Reccuring Items |
(2)
|
(3)
|
(2)
|
(2)
|
(3)
|
(6)
|
(17)
|
(4)
|
(4)
|
(1)
|
(4)
|
(0)
|
(2)
|
(2)
|
(8)
|
(5)
|
(3)
|
(2)
|
552
|
(2)
|
(2)
|
(3)
|
(16)
|
(13)
|
(16)
|
(15)
|
(3)
|
(2)
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
|
| Total Other Income |
8
|
5
|
0
|
1
|
(1)
|
(1)
|
(2)
|
(2)
|
0
|
(3)
|
(1)
|
(1)
|
(1)
|
3
|
(2)
|
(2)
|
(2)
|
(2)
|
(1)
|
(1)
|
(1)
|
(0)
|
2
|
(1)
|
(0)
|
(1)
|
2
|
3
|
0
|
1
|
(2)
|
(2)
|
(1)
|
(1)
|
|
| Pre-Tax Income |
238
N/A
|
250
+5%
|
253
+1%
|
297
+17%
|
311
+5%
|
296
-5%
|
249
-16%
|
239
-4%
|
217
-9%
|
220
+1%
|
228
+4%
|
200
-12%
|
118
-41%
|
63
-47%
|
33
-47%
|
558
+1 580%
|
595
+7%
|
552
-7%
|
453
-18%
|
(114)
N/A
|
(122)
-7%
|
(70)
+43%
|
40
N/A
|
86
+114%
|
73
-14%
|
77
+5%
|
81
+6%
|
57
-30%
|
46
-20%
|
58
+26%
|
60
+4%
|
6
-90%
|
(66)
N/A
|
(206)
-211%
|
|
| Net Income | |||||||||||||||||||||||||||||||||||
| Tax Provision |
(57)
|
(65)
|
(72)
|
(79)
|
(67)
|
(60)
|
(45)
|
(44)
|
(41)
|
(48)
|
(54)
|
(48)
|
(34)
|
(17)
|
(7)
|
1
|
(9)
|
(6)
|
(103)
|
(102)
|
(96)
|
(101)
|
(14)
|
(19)
|
(15)
|
(11)
|
(11)
|
(8)
|
(2)
|
(7)
|
(5)
|
2
|
3
|
12
|
|
| Income from Continuing Operations |
181
|
186
|
181
|
219
|
244
|
236
|
204
|
195
|
176
|
172
|
174
|
152
|
85
|
46
|
27
|
559
|
586
|
546
|
350
|
(215)
|
(217)
|
(171)
|
27
|
67
|
58
|
65
|
70
|
49
|
44
|
50
|
55
|
8
|
(63)
|
(194)
|
|
| Income to Minority Interest |
0
|
0
|
0
|
0
|
0
|
1
|
1
|
2
|
2
|
3
|
3
|
4
|
4
|
3
|
3
|
2
|
1
|
1
|
1
|
2
|
3
|
3
|
4
|
4
|
4
|
4
|
4
|
4
|
4
|
4
|
4
|
3
|
3
|
3
|
|
| Net Income (Common) |
181
N/A
|
186
+3%
|
181
-2%
|
219
+21%
|
245
+12%
|
237
-3%
|
206
-13%
|
197
-4%
|
178
-10%
|
175
-2%
|
177
+1%
|
156
-12%
|
88
-43%
|
49
-45%
|
29
-40%
|
561
+1 813%
|
587
+5%
|
547
-7%
|
351
-36%
|
(214)
N/A
|
(215)
-1%
|
(167)
+22%
|
30
N/A
|
71
+134%
|
62
-12%
|
69
+11%
|
74
+7%
|
53
-28%
|
48
-10%
|
54
+13%
|
59
+8%
|
11
-81%
|
(60)
N/A
|
(191)
-218%
|
|
| EPS (Diluted) |
0.76
N/A
|
0.78
+3%
|
0.71
-9%
|
0.69
-3%
|
0.77
+12%
|
0.75
-3%
|
0.65
-13%
|
0.63
-3%
|
0.57
-10%
|
0.56
-2%
|
0.57
+2%
|
0.5
-12%
|
0.29
-42%
|
0.16
-45%
|
0.09
-44%
|
1.81
+1 911%
|
1.89
+4%
|
1.76
-7%
|
1.13
-36%
|
-0.69
N/A
|
-0.69
N/A
|
-0.54
+22%
|
0.1
N/A
|
0.23
+130%
|
0.2
-13%
|
0.22
+10%
|
0.24
+9%
|
0.17
-29%
|
0.15
-12%
|
0.17
+13%
|
0.19
+12%
|
0.04
-79%
|
-0.18
N/A
|
-0.6
-233%
|
|
Switch to:
Switch to:
See Also
Discover More
